Close
  Indian J Med Microbiol
 

Table 2: Efficacy outcomes in patients with plaque psoriasis after treatment with biosimilar adalimumab for 16 weeks

Table 2: Efficacy outcomes in patients with plaque  psoriasis after treatment with biosimilar adalimumab for 16 weeks